10-K
REGENERON PHARMACEUTICALS, INC.
- Company
- REGENERON PHARMACEUTICALS, INC.
- Filed
- March 22, 2002
- Period of Report
- December 31, 2001
- Accession Number
- 0000950123-02-002817
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →